Form 8-K - Current report:
SEC Accession No. 0001193125-16-424905
Filing Date
2016-01-08
Accepted
2016-01-08 16:29:05
Documents
1
Period of Report
2016-01-08
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d100288d8k.htm 8-K 19412
  Complete submission text file 0001193125-16-424905.txt   20634
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 161333567
SIC: 2834 Pharmaceutical Preparations